Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Nelson

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|October 1, 2005
Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphomaMichael J Robertson, Rafat Abonour, Robert Hromas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignanciesMichael J Robertson, David Pelloso, Rafat Abonour, et al.
Clinical Immunology (Orlando, Fla.)|January 14, 2014
Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency diseaseStephen Jolles, Michael Borte, Robert P Nelson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 3, 2005
Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn diseaseSrinivasan Ramanuja, Karen M Wolf, Mohammed A Sadat, et al.
Journal of Clinical Immunology|September 25, 2008
Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficienciesMark R Stein, Robert P Nelson, Joseph A Church, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
Prognostic biomarkers for acute graft-versus-host disease risk after cyclophosphamide-fludarabine nonmyeloablative allotransplantationRobert P Nelson, Muhammad Rizwan Khawaja, Susan M Perkins, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Opportunistic infections in a patient with HIV and thymomaCarrie A Leathers, Marwan M Azar, Sunil S Badve, et al.
BMC Systems Biology|August 27, 2017
An Integrative multi-lineage model of variation in leukopoiesis and acute myelogenous leukemiaJoyatee M Sarker, Serena M Pearce, Robert P Nelson, et al.
Transplantation|June 14, 2006
Serial transplantation resulting in tolerance to an unrelated cord blood graftW Scott Goebel, Robert P Nelson, Zacharie Brahmi, et al.
Journal of Pediatric Hematology/Oncology|March 16, 2007
Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency diseaseSrilatha Atluri, Kathleen Neville, Mary Davis, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|October 1, 2005
Augmented high-dose regimen of cyclophosphamide, carmustine, and etoposide with autologous hematopoietic stem cell transplantation for relapsed and refractory aggressive non-Hodgkin's lymphomaMichael J Robertson, Rafat Abonour, Robert Hromas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Interleukin 12 immunotherapy after autologous stem cell transplantation for hematological malignanciesMichael J Robertson, David Pelloso, Rafat Abonour, et al.
Clinical Immunology (Orlando, Fla.)|January 14, 2014
Long-term efficacy, safety, and tolerability of Hizentra® for treatment of primary immunodeficiency diseaseStephen Jolles, Michael Borte, Robert P Nelson, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|September 3, 2005
Newly diagnosed chronic granulomatous disease in a 53-year-old woman with Crohn diseaseSrinivasan Ramanuja, Karen M Wolf, Mohammed A Sadat, et al.
Journal of Clinical Immunology|September 25, 2008
Safety and efficacy of Privigen, a novel 10% liquid immunoglobulin preparation for intravenous use, in patients with primary immunodeficienciesMark R Stein, Robert P Nelson, Joseph A Church, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
Prognostic biomarkers for acute graft-versus-host disease risk after cyclophosphamide-fludarabine nonmyeloablative allotransplantationRobert P Nelson, Muhammad Rizwan Khawaja, Susan M Perkins, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 26, 2014
Opportunistic infections in a patient with HIV and thymomaCarrie A Leathers, Marwan M Azar, Sunil S Badve, et al.
BMC Systems Biology|August 27, 2017
An Integrative multi-lineage model of variation in leukopoiesis and acute myelogenous leukemiaJoyatee M Sarker, Serena M Pearce, Robert P Nelson, et al.
Transplantation|June 14, 2006
Serial transplantation resulting in tolerance to an unrelated cord blood graftW Scott Goebel, Robert P Nelson, Zacharie Brahmi, et al.
Journal of Pediatric Hematology/Oncology|March 16, 2007
Epstein-Barr-associated leiomyomatosis and T-cell chimerism after haploidentical bone marrow transplantation for severe combined immunodeficiency diseaseSrilatha Atluri, Kathleen Neville, Mary Davis, et al.
Pageof 4